Literature DB >> 7334079

Serum cryptococcal antigen determination in the presence of rheumatoid factor.

R H Eng, A Person.   

Abstract

Sera from nine patients with cryptococcal infections and from four with rheumatoid arthritis and positive rheumatoid factor were examined for the presence of cryptococcal capsular antigen by the latex agglutination method. Ethylenediaminetetraacetic acid-heat treatment of the sera before testing possibly increased sensitivity as compared with the untreated sera, and the interfering rheumatoid factor activity was eliminated.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7334079      PMCID： PMC274028          DOI： 10.1128/jcm.14.6.700-702.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  DETECTION OF CRYPTOCOCCUS NEOFORMANS ANTIGEN IN BODY FLUIDS BY LATEX PARTICLE AGGLUTINATION.

Authors:  N BLOOMFIELD; M A GORDON; D F ELMENDORF
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

2.  Elimination of rheumatoid factor in the latex test for cryptococcosis.

Authors:  M A Gordon; E W Lapa
Journal:  Am J Clin Pathol       Date:  1974-04       Impact factor: 2.493

3.  Control for rheumatoid factor in the latex test for cryptococcosis.

Authors:  J E Bennett; J W Bailey
Journal:  Am J Clin Pathol       Date:  1971-09       Impact factor: 2.493

4.  Serologic grouping of Cryptococcus neoformans.

Authors:  D E Wilson; J E Bennett; J W Bailey
Journal:  Proc Soc Exp Biol Med       Date:  1968-03

5.  Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen.

Authors:  J S Goodman; L Kaufman; M G Koenig
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

6.  Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions.

Authors:  S O Doskeland; B P Berdal
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

7.  Serologic tests in diagnosis and prognosis of cryptococcosis.

Authors:  M A Gordon; D K Vedder
Journal:  JAMA       Date:  1966-09-19       Impact factor: 56.272

8.  Commercial cryptococcal latex kit: clinical evaluation in a medical center hospital.

Authors:  E Prevost; R Newell
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948
  8 in total
  10 in total

1.  Corrected version specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors.

Authors:  L Stockman; G D Roberts
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

2.  Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen.

Authors:  L D Gray; G D Roberts
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

3.  Effect of potential interference factors on performance of enzyme immunoassay and latex agglutination assay for cryptococcal antigen.

Authors:  H D Engler; Y R Shea
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

4.  Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen.

Authors:  T C Wu; S Y Koo
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

5.  Specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors.

Authors:  L Stockman; G D Roberts
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

6.  Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment.

Authors:  J R Hamilton; A Noble; D W Denning; D A Stevens
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  Improved detection of bacterial antigens by latex agglutination after rapid extraction from body fluids.

Authors:  L P Smith; K W Hunter; V G Hemming; G W Fischer
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

8.  Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents.

Authors:  F Nato; J C Mazie; J M Fournier; B Slizewicz; N Sagot; M Guibourdenche; D Postic; J Y Riou
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

9.  Elimination of false-positive serum reactivity in latex agglutination test for cryptococcal antigen in human immunodeficiency virus-infected population.

Authors:  S Whittier; R L Hopfer; P Gilligan
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  The course of cryptococcal capsular polysaccharide antigenemia/human cryptococcal polysaccharide elimination kinetics.

Authors:  R Eng; H Chmel; M Corrado; S M Smith
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.